Combined interferon α2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†

Robert G. Knodell, Kamal G. Ishak, William C. Black et al. · Hepatology · 1981 · 3.6K citations · Full text

Medicine, Pathology, Hepatology +16

Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C

John G. McHutchison, Stuart C. Gordon, Eugene R. Schiff et al. · New England Journal of Medicine · 1998 · 3.5K citations · Full text

Pharmacy, Pharmacotherapy, Hepatic Pharmacotherapy +16

Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

Thierry Poynard, Patrick Marcellin, Samuel S. Lee et al. · The Lancet · 1998 · 2.3K citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B

Jeremy Luban, K L Bossolt, E K Franke et al. · Cell · 1993 · 805 citations

Life Sciences, Immunology, Molecular Biology +6

The Long–Term Pathological Evolution of Chronic Hepatitis C

Michitami Yano, H. Kumada, M. Kage et al. · Hepatology · 1996 · 583 citations

Medicine, Infectious Diseases, Pathology +17